241 related articles for article (PubMed ID: 34703811)
1. Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population.
Khanum I; Kumar L; Awan S; Jamil B
Clin Exp Vaccine Res; 2021 Sep; 10(3):276-281. PubMed ID: 34703811
[TBL] [Abstract][Full Text] [Related]
2. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
[TBL] [Abstract][Full Text] [Related]
3. Factors determining COVID-19 pneumonia severity in a country with routine BCG vaccination.
Aksu K; Naziroğlu T; Özkan P
Clin Exp Immunol; 2020 Nov; 202(2):220-225. PubMed ID: 32813879
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.
Sinha S; Ajayababu A; Thukral H; Gupta S; Guha SK; Basu A; Gupta G; Thakur P; Lingaiah R; Das BK; Singh UB; Singh R; Narang R; Bhowmik D; Wig N; Modak DC; Bandyopadhyay B; Chakrabarty B; Kapoor A; Tewari S; Prasad N; Hashim Z; Nath A; Kumari N; Goswami R; Pandey S; Pandey RM
Infect Dis Ther; 2022 Dec; 11(6):2205-2217. PubMed ID: 36242739
[TBL] [Abstract][Full Text] [Related]
5. BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial.
Claus J; Ten Doesschate T; Gumbs C; van Werkhoven CH; van der Vaart TW; Janssen AB; Smits G; van Binnendijk R; van der Klis F; van Baarle D; Paganelli FL; Leavis H; Verhagen LM; Joosten SA; Bonten MJM; Netea MG; van de Wijgert JHHM;
mBio; 2023 Apr; 14(2):e0035623. PubMed ID: 36976004
[TBL] [Abstract][Full Text] [Related]
6. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
Front Immunol; 2021; 12():801799. PubMed ID: 35222355
[TBL] [Abstract][Full Text] [Related]
7. Exploring the role of bacillus calmette-guerin vaccination in protection against COVID-19.
Chauhan A; Singh M; Agarwal A; Jaiswal N; M Lakshmi PV; Singh M
Int J Mycobacteriol; 2021; 10(4):433-436. PubMed ID: 34916464
[TBL] [Abstract][Full Text] [Related]
8. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
9. The retrospective study of the metabolic patterns of BCG-vaccination in type-2 diabetic individuals in COVID-19 infection.
Anwardeen NR; Cyprian FS; Yassine HM; Al-Thani AA; Abdallah AM; Emara MM; Elrayess MA
Front Immunol; 2023; 14():1146443. PubMed ID: 37122708
[TBL] [Abstract][Full Text] [Related]
10. Association between presence of Bacillus Calmette-Guerin vaccine scar and coronavirus disease 2019.
Caliskaner Ozturk B; Vardaloglu I; Ongel Harbiyeli D; Gungordu N; Senkardesler G; Aliyeva N; Ismayilova A; Can G; Balkan II; Gemicioglu B; Borekci S
Medicine (Baltimore); 2022 Dec; 101(48):e32185. PubMed ID: 36482635
[TBL] [Abstract][Full Text] [Related]
11. Effects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infection.
Chowdhury UN; Faruqe MO; Mehedy M; Ahmad S; Islam MB; Shoombuatong W; Azad AKM; Moni MA
Comput Biol Med; 2021 Nov; 138():104891. PubMed ID: 34624759
[TBL] [Abstract][Full Text] [Related]
12. The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections.
Föhse K; Taks EJM; Moorlag SJCFM; Bonten MJM; van Crevel R; Ten Oever J; van Werkhoven CH; Netea MG; van de Maat JS; Hoogerwerf JJ
Front Immunol; 2023; 14():980711. PubMed ID: 36875134
[TBL] [Abstract][Full Text] [Related]
13. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Charoenlap S; Piromsopa K; Charoenlap C
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
[TBL] [Abstract][Full Text] [Related]
14. Previous BCG vaccination is associated with less severe clinical progression of COVID-19.
Pereira SM; Barreto FR; de Souza RA; de Souza Teles Santos CA; Pereira M; da Paixão ES; de Jesus Lima CCO; da Natividade MS; Lindoso AABP; Fernandes EG; Junior EBC; Pescarini JM; de Andrade KVF; de Souza FM; de Britto EA; Nunes C; Ichihara MY; Dalcolmo M; Trajman A; Barral-Netto M; Abubakar I; Barreto ML; de Alencar Ximenes RA; Rodrigues LC
BMC Med; 2023 Apr; 21(1):145. PubMed ID: 37055776
[TBL] [Abstract][Full Text] [Related]
15. A Survey Among Italian Physicians During COVID-19 Outbreak. Could Bacillus Calmette-Guérin Vaccine Be Effective Against SARS-CoV2?
Patella V; Sanduzzi A; Bruzzese D; Florio G; Brancaccio R; Fabbrocini G; Delfino G
Front Pharmacol; 2021; 12():646570. PubMed ID: 34012395
[No Abstract] [Full Text] [Related]
16. Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration.
Ayoub BM; Ramadan E; Ashoush N; Tadros MM; Hendy MS; Elmazar MM; Mousa SA
Pharmazie; 2020 Aug; 75(8):375-380. PubMed ID: 32758336
[TBL] [Abstract][Full Text] [Related]
17. Impact of Routine Infant BCG Vaccination on COVID-19.
Kinoshita M; Tanaka M
J Infect; 2020 Oct; 81(4):625-633. PubMed ID: 32795481
[TBL] [Abstract][Full Text] [Related]
18. Off-target effects of bacillus Calmette-Guérin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19.
Messina NL; Germano S; McElroy R; Rudraraju R; Bonnici R; Pittet LF; Neeland MR; Nicholson S; Subbarao K; Curtis N;
Clin Transl Immunology; 2022; 11(4):e1387. PubMed ID: 35573165
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Severity and Neonatal BCG Vaccination among Young Population in Taiwan.
Su WJ; Chang CH; Wang JL; Chen SF; Yang CH
Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33919644
[TBL] [Abstract][Full Text] [Related]
20. BCG vaccination and the risk of COVID 19: A possible correlation.
Ahmed SM; Nasr MA; Elshenawy SE; Hussein AE; El-Betar AH; Mohamed RH; El-Badri N
Virology; 2022 Jan; 565():73-81. PubMed ID: 34742127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
